• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Economics, not race, sways mammo follow-up decision

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 1
Volume 32
Issue 1

African American women take longer to come in for follow-up care after a suspicious breast abnormality is found, according to a study from the University of South Carolina. The problem may have more to do with economics than race.

African American women take longer to come in for follow-up care after a suspicious breast abnormality is found, according to a study from the University of South Carolina. The problem may have more to do with economics than race.

Lead author Swann A. Adams, Ph.D., and colleagues selected 729 African American women and 901 European American women from more than 50,000 screenings in South Carolina's Best Chance Network. The network provides free mammography screening to economically disadvantaged women. Black women took slightly longer to follow up after an abnormality was found than did their white counterparts (Cancer 2009 Oct 26. Epub ahead of print).

Mistrust and poor communication between patient and doctor, lack of transportation, and proximity of clinics to the patient may cause delays, Adams said.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.